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Arc is a cellular immediate-early gene (IEG) that func-
tions at excitatory synapses and is required for
learning and memory. We report crystal structures
of Arc subdomains that form a bi-lobar architecture
remarkably similar to the capsid domain of human
immunodeficiency virus (HIV) gag protein. Analysis
indicates Arc originated from the Ty3/Gypsy retro-
transposon family and was ‘‘domesticated’’ in higher
vertebrates for synaptic functions. The Arc N-termi-
nal lobe evolved a unique hydrophobic pocket that
mediates intermolecular binding with synaptic pro-
teins as resolved in complexes with TARPg2 (Starga-
zin) and CaMKII peptides and is essential for Arc’s
synaptic function. A consensus sequence for Arc
binding identifies several additional partners that
include genes implicated in schizophrenia. Arc N-
lobe binding is inhibited by small chemicals suggest-
ing Arc’s synaptic action may be druggable. These
studies reveal the remarkable evolutionary origin of
Arc and provide a structural basis for understanding
Arc’s contribution to neural plasticity and disease.
INTRODUCTION
Information storage in the brain is mediated by changes in syn-
aptic strength that require rapid de novo synthesis of mRNA
and protein (Goelet et al., 1986). Arc provides an exemplary
molecule for studies of how the de novo response contributes
to memory. Arc was identified based on its rapid transcriptional
upregulation in models of learning (Link et al., 1995; Lyford et al.,
1995), and its transcription is tightly linked to neural activity that
underlies information processing and storage (Guzowski et al.,
1999). Genetic deletion of Arc results in deficits of memory
without altering behaviors essential for learning (Plath et al.,
2006). Arc is a postsynaptic protein that associates with endo-
cytic vesicular proteins to modulate the trafficking of AMPA-490 Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc.type glutamate receptors (Chowdhury et al., 2006; Shepherd
et al., 2006). Arc also binds CaMKII in the kinase inactive state,
and this interaction targets Arc to synapses in accordance (in-
verse) with their history of activity, and underlies Arc’s contribu-
tion to homeostatic maintenance of distributed synaptic weights
(Okuno et al., 2012). Arc contributes importantly to cell-wide
homeostatic scaling (non-Hebbian) (Shepherd et al., 2006) and
synapse-specific (Hebbian) plasticity (Be´ı¨que et al., 2011; Jak-
kamsetti et al., 2013; Park et al., 2008; Waung et al., 2008). Arc
has been implicated in diseases of cognition where its action is
thought to contribute to reduced synaptic strength. Inhibitory
control of Arc translation is disrupted in fragile X mental retarda-
tion syndrome and unregulated expression of Arc contributes to
enhanced mGluR-LTD (Niere et al., 2012; Park et al., 2008;
Waung et al., 2008). In Angelman syndrome, reduced ubiquitina-
tion of Arc may result in an increase of Arc-dependent synaptic
downregulation (Greer et al., 2010). Arc enhances the associa-
tion of g-secretase with trafficking endosomes that process am-
yloid precursor protein (APP) to Aß peptide. This action of Arc
creates activity-dependent increases of Aß that contribute to
amyloid deposition (Wu et al., 2011). Mutations of genes whose
protein products can physically associate with Arc were identi-
fied in studies of sporadic and inherited schizophrenia (Fromer
et al., 2014; Purcell et al., 2014).
Arc’s functions have been challenging to understand inmolec-
ular detail because Arc is a single copy gene without identifiable
familymembers or biochemically defined domains. For example,
Arc is known to downregulate synaptic AMPA-type glutamate
receptors, but the binding partners and regulatory mechanisms
that couple Arc to AMPA receptor trafficking remain unknown.
Arc’s association with cognitive diseases suggests that knowl-
edge of physical associations that define its binding properties
could provide insight into pathogenesis. To address this chal-
lenge, we evaluated known interactions of Arc and assessed
whether they could be reconstituted with recombinant proteins.
We discovered that both full-length Arc, aswell as a specific sub-
domain of Arc, bound CaMKII. This same subdomain of Arc was
found to bind to TARPg2 (Stargazin), which is known to asso-
ciate with AMPA receptors and mediate critical aspects of
AMPA receptor trafficking (Jackson and Nicoll, 2011). Co-crystal
structures of an Arc subdomain bound to CaMKII and TARPg2
were defined and reveal the structural basis of these interac-
tions. Physiological studies demonstrate that synaptic AMPA re-
ceptor downregulation during homeostatic scaling requires Arc
N-lobe binding. Remarkably, the subdomain that mediates Arc
binding is structurally similar to the capsid domain of human im-
munodeficiency virus (HIV). A structure of a second subdomain
of Arc further substantiates a bi-lobar configuration that is similar
to HIV GAG protein and indicates Arc originated from the Ty3/
Gypsy retrotransposon family. Analysis across species reveals
the evolutionary origin of its unique binding domain. An Arc N-
lobe consensus binding sequence was established that iden-
tifies several novel binding partners that include proteins of the
‘‘Arc complex’’ linked to schizophrenia (Fromer et al., 2014; Pur-
cell et al., 2014). Arc N-lobe binding is dependent on buried
hydrophobic interactions that are notably distinct from many
protein-protein interactions and this prompted us to screen for
and identify small molecules that can inhibit Arc N-lobe binding.
These observations provide a structural basis for understanding
critical functions of Arc in synaptic plasticity and cognitive dis-
eases and support the possibility that Arc functions may phar-
macologically targetable.
RESULTS
Evolutionary Origin of Arc from Ty3/Gypsy
Retrotransposon and Phyla-Specific Domestication
The Arc-CaMKII interaction was previously characterized in co-
immunoprecipitation assays (Okuno et al., 2012). We discovered
the Arc-TARPg2 interaction in a survey of synaptic proteins that
co-immunoprecipitate with Arc (Figure S1A). TARPg2 associates
with AMPA receptors and modulates AMPA receptor trafficking
and localization to the synapse (Jackson and Nicoll, 2011). Rat
Arc (Rn Arc) bound TARPg2 peptide (see Figure 2) and CaMKIIa
peptide (Figure S1B) in vitro. Full-length RnArc did not crystallize,
but RnArc (207–278) crystallized in complex with TARPg2 and
CaMKII peptides (Table S1). Crystal structures revealed RnArc
(207–278) forms a four helical bundle (Figure 1A) that is structur-
ally similar to capsid domains of retroviral gag proteins in the
PDB database, including HIV and Rous Sarcoma Virus (RSV)
(Figures 1A and 1C and Figures S2A and S2B). No other struc-
tures were significantly similar. HIV capsid is typical of retrovi-
ruses and includes two globular domains termed NTD and
CTD (Pornillos et al., 2009, 2011). While sequence identity is
only 11%, RnArc (207–278) superposes on the HIV CTD with a
root-mean-square deviation (RMSD) of 2.6 A˚ for 61 Cas. RnArc
(207–278) includes an additional b1-strand at its N terminus
that contacts the a1-helix and surrounds the bound TARPg2
peptide (Figure 1A). Similarity between Arc and HIV capsid pro-
tein was further borne out with the structure of RnArc (278–370)
apoprotein (Table S1), which is also superimposable with HIV
capsid protein CTD. RnArc (278–370) possesses a more exten-
sive a1’ helix at the N terminus of the major homology region
(MHR) than retroviruses (Figures 1B and 1C). We term RnArc
(207–278) Arc N-lobe, and RnArc (278-370) Arc C-lobe; together
they form the Arc Gag domain.
Sequence analysis reveals bi-lobar Arc domains in all meta-
zoans (Figures 1C and 1D). Arc is highly conserved in mammals,
birds, and reptiles. The bi-lobar Arc domain in the fish Danio (Dr)appears in three genes that are members of the Ty3/Gypsy fam-
ily of retrotransposons. Ty3/Gypsy are ancient forms of RNA-
based self-replicating elements that are present in animal, plant,
and fungal kingdoms and are considered ancestral to modern
retroviruses, including HIV (Llorens et al., 2008), as well as
certain cellular genes (Campillos et al., 2006; Volff, 2009). The
fishDanio Arc genes Dr1 andDr3 encode domains typical of Ret-
rotansposons including zinc knuckles, which bind RNA during
virion assembly, as well as reverse transcriptase (RT) (Figure 1D).
These observations confirm computational predictions of Arc’s
retrotransposon origin (Campillos et al., 2006). Danio gene Dr2
is different from Dr1 and Dr3 in that it possesses an N-terminal
coiled-coil domain, which is typical of all higher vertebrate Arc
genes, and lacks the zinc knuckle domain. This suggests that
vertebrate Arc arose through the ‘‘domestication’’ (repurposing
of retrotransposon genes in eukaryotic cells; see Campillos
et al., 2006) of Ty3/Gypsy in stages that include acquiring the
N-terminal coil-coil and loss of the zinc knuckle and RT.
The Arc bi-lobar domain is also present in insects. Arc in
beetle Tribolium castaneum (Tca) includes zinc knuckles and
reverse transcriptase, while Drosophila Arc1 protein includes
zinc knuckles but lacks reverse transcriptase (Figure 1D). Insect
Arc lacks the N-terminal CC domain typical of vertebrate Arc.
This suggests that Arc domestication in insects followed a
different functional path and is consistent with studies of Dme
Arc that define a role in stress-induced behavior but not learning
and memory (Mattaliano et al., 2007).
A retrotransposon is present in plant Fragaria vesca that
possesses 14% identity to RnArc within the GAG domain.
However, this plant gene appears to be a different family of
retrotransposon based on sequence of the nucleotide binding
domain encoding CHHC zinc knuckle motif, not CCHC motif
(Figure 1E).
Determinants of Arc N-Lobe Structure Important for
Binding to TARPg2
We examined determinants of Arc binding to TARPg2. TARPg2
passes through the hydrophobic core of the Arc N-lobe four helix
bundle (Figures 2A and 2B). The small A250 side chain together
with P217 creates space for interactions with TARPg2 Y229 ar-
omatic ring. RnArc (207–370) mutations P217F and P217V that
fill the pocket and mimic Dme Arc or retroviral Gag (Figure 1C)
abolish binding to TARPg2 peptide (Figure 2C). Thus, TARPg2
Y229 appears to replace an aromatic stack that assembles the
four helices of retroviral/HIV Gag proteins. Arc strand b1, loop
T3, and the N terminus of helix a3 create a groove that surrounds
the peptide (Figures 2A and 2B). This groove also appears impor-
tant for binding since RnArc (207–370) F214S, which mimics
Xenopus Arc and encodes an aromatic pocket but not the aro-
matic pair F214-H223 required to anchor b1 strand to helix a1,
fails to bind (Figure 2C). As predicted, Xenopus Arc does not
bind TARPg2 (Figure S3A). The evolutionary origin and progres-
sion suggest Arc N-lobe binding is unique to the vertebrate
genome.
To further assess determinants of peptide binding, we devel-
oped a binding assay that monitors the polarization of light
emitted from a 5-Carboxyfluorescein-tagged TARPg2 peptide
(fluorescence polarization assay [FP]) (Moerke, 2009; RoehrlNeuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc. 491
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Figure 1. Evolutionary Origin of Arc from Retrotransposon
(A and B) Superposition of Arc N-lobe or C-lobe (blue and orange, respectively) with HIV capsid C-lobe (PDB: 1A43; yellow). The RMSD in Ca positions for
superposition of the N-lobe (excluding residues 207–214) and C-lobe are 2.6 and 2.3 A˚, respectively. The TARPg2 peptide complexed with Arc N-lobe is colored
purple. Helix labels in parentheses followed the reference for HIV capsid domain (Pornillos et al., 2009, 2011).
(C) The sequence alignment for typical species based on their 3D structural superposition with retrotransposon or retrovirus (PDB: 1A43, HIV capsid C-lobe; 3G29,
RousSarcomaVirus). Hs,Homosapiens, Genbank:NP_056008.1;Rn,Rattusnorvegicus, Genbank:NP_062234.1;Gga,Gallusgallus, Genbank:NP_989763.1;Aca,
Anolis carolinensis, XP_003223977.1; Xtr, Xenopus (Silurana) tropicalis, XP_002934511.1; Dme, Drosophila melanogaster, Arc1, Q7K1U0; Dr2, Danio rerio,
XP_001919627; _N and _C refer toN-lobe andC-lobe, respectively. Secondary structures of ArcN-lobe andHIVC-lobe (PDB: 1A43) are shownon the top in red and
blue, respectively. Arc C-lobe secondary structure is on the bottom. Residues forming the hydrophobic pocket in Arc N-lobe are marked with a red star above the
sequencealignment.Thepair of aromatic residuesanchoringN-terminalbeta strandonalphahelixbundlecore ishighlightedwithyellowsolidcircles. Thenumbers in
the box indicate three categories (1, N-lobes; 2, Virus; 3, C-lobes). The conservative residues across different species are marked in gray.
(D)DomainorganizationofArc homologsandseveral retrotransposons from typical species. ArcN-lobeandC-lobe regionarecoloredblueandorange, respectively.
CCHC labels zinc knuckle. Other domains of retrotransposon, namely RT (reverse transcriptase), RH (RNase HI), and INT (Integrase), are shown in pink.
(E) The phylogenetic tree inferred based on the concatenated analysis of capsid domains from typical species. Oan,Ornithorhynchus anatinus, XP_001512750.1;
Dr1, Danio rerio, XP_005157614; DR3,Danio rerio, XP_005156176.1; Tca1, Tribolium castaneum, XP_001812244; Tca2, Tribolium castaneum, XP_001807351.1;
Sbi, Sorghum bicolor, XP_002457951.1; Fr, Fragaria vesca subsp.Vesca, XP_004301673.1.
492 Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc.
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Figure 2. Complex Structure of the ArcN-Lobe
with TARPg2 Fragment
(A) Stick representation of hydrophobic pocket at the
binding site in two views rotated by 90. TARPg2
peptide is colored purple. Residues anchoring b1-
strand of Arc N-lobe are shown in yellow. Residues
forming pocket wall are show in cyan.
(B) Molecular surface representation of Arc N-lobe
complexed with TARPg2 peptide (in purple) showing
the hydrophobic pocket and binding tunnel in two
views.
(C) Binding of WT Arc GAG domain (207–370) and
point mutants to TARPg2 fragment (221–247) deter-
mined by in vitro pull-down experiments using GST-
fusion constructs (bottom panel without peptide). The
mutation to one aromatic A.A. at residue S275 on the
bottom of the hydrophobic pocket had no effect on
Arc binding to TARPg2 fragment.
(D) Measurement of Kd and relative affinity for Arc
GAG domain (207–370) and point mutants using
fluorescence polarization assay with 5-Carboxy-
fluorescein tagged TARPg2 peptide (225-RIPSYR-
230).et al., 2004) and performed binding assays with labeled peptide.
TARPg2 peptide (RIPSYR) binding affinity is60 mM (Figure 2D).
Competition binding assays demonstrated similar binding to the
entire C terminus of TARPg2 (aa 202–23). This affinity is similar to
that of the PDZ domain of PSD95 binding with several of its li-
gands (Møller et al., 2013) and is consistent with a role for Arc
N-lobe binding in protein-protein interactions at the synapse.
RnArc (207–370) mutations F214S and P217F abolish binding
to TARPg2 peptide (Figures 2C and 2D). These observations
confirm that Arc binding requires both the b’ tunnel and the aro-
matic pocket.
Arc N-Lobe Binding Site Is Required for Trafficking of
TARPg2 and AMPA Receptor during Homeostatic
Scaling
We assessed the physiological role of Arc N-lobe binding by ex-
pressing full-length WT Arc or ArcP217F in DIV14 neuronal cul-
tures by Sindbis virus. Transgene expression was monitored
by western blot and confirmed similar expression of WT Arc orNeuron 86, 49ArcP217F (Figure 3A). Transgene expres-
sion was also monitored by co-expression
of GFP, which was typically detected in
80% of neurons (data not shown). Neu-
rons were treated with TTX to suppress syn-
aptic activity, and thereby reduce expres-
sion of native Arc (Shepherd et al., 2006),
during viral gene expression (12–16 hr).
Consistent with previous studies, WT Arc
transgene reduced expression of AMPA re-
ceptor GluA1 on the membrane surface as
assayed by biotinylation of surface proteins
(Figures 3A and 3B). TARPg2 was also
prominently downregulated by WT Arc,
consistent with its role as a binding partner
of GluA1 and regulator of trafficking. Bycontrast, ArcP217F did not downregulate surface GluA1 or
TARPg2. Since Arc does not bind GluA1 directly (Chowdhury
et al., 2006), this supports the hypothesis that Arc binding to
TARPg2 mediates GluA1 downregulation. Recordings from
viral-transfected neurons confirmed that the mEPSC amplitude
and frequency were reduced in neurons expressing WT Arc
compared to ArcP217F (Figure 3C). These data establish that
Arc-N lobe binding is essential for Arc-dependent downregula-
tion of synaptic strength. It should be noted that the larger ampli-
tude of mEPSCs in ArcP217F increases detection and leaves
open the question of whether there are truly more synapses or
just more detected.
Ligand Determinants Reveal Regulatory Mechanisms
and Consensus Sequence for Arc Binding
An electron density map of the bound TARPg2 peptide reveals
features of the ligand that are important for binding (Figure 4A).
Hydrogen bonds are present to both main chain and side chain
positions (Figure 4B). TARPg2 is a member of type I TARPs,0–500, April 22, 2015 ª2015 Elsevier Inc. 493
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Figure 3. Arc N-Lobe Binding Is Required for Synaptic Function
(A) Surface biotinylation and western blotting assay showing Arc WT expression decreases surface GluA1 and TARPg2 levels, while Arc P217F mutant does not.
(B) Quantification of surface to total GluA1 and TARPg2. Arc WT expression results in significant decrease of surface GluA1 and TARPg2. Arc P217F mutant
expression has no effect on surface GluA1 or TARPg2. n = 9; **p < 0.01; ***p < 0.0001.
(C) Representative traces fromwhole-cell recordings ofWT Arc or Arc P217F overexpression. (Scale = 20 pA, 200ms). Histogram represents the averagemEPSC
amplitude of each population. mEPSCs are decreased in neurons expressing WT Arc relative to ArcP217F-expressing neurons. **p < 0.01.which include TARPg3, TARPg4, and TARPg8 (Tomita et al.,
2003). The Arc binding motif is conserved in TARPg4 and
TARPg8, but TARPg3 encodes proline rather than serine at po-
sition 228 in higher vertebrates (Figure S3B). This substitution
interferes with b strand formation. RnArc (207–370) bound
GST-TARPg2 but not GST-TARPg3 (Figure 4C), consistent
with a requirement for b strand. The non-binding form of
TARPg3 appears to be an evolutionary adaptation in higher ver-
tebrates since Xenopus and Danio TARPg3 encode S228 (Fig-
ure S3B). Another regulatory mechanism is suggested by the
observation that TARPg2 is dynamically phosphorylated and
dephosphorylated in association with synaptic potentiation or
depression, respectively (Opazo et al., 2010; Sumioka et al.,
2010; Tomita et al., 2005). One of these phosphorylation sites
TARPg2(S228) (Figure S3B) is predicted to disrupt hydrogen
bonds made by the side chain hydroxyl and introduce steric
clashes with I213 and N247 (Figure 4B). RnArc (207–370)
bound GST-TARPg2 but not a TARPg2 peptide with phospho-
mimetic substitutions (Sumioka et al., 2010) (Figure 4D and
Figure S3B).
We used the FP competition binding assay to assess determi-
nants of binding affinity. We began by examining effects of mu-
tations of the TARPg2 peptide on Arc binding. Phosphorylation
of TARPg2(S228) or TARPg2(Y229) reduced binding affinity at
least 20-fold (Figure 4E). A minimal tripeptide corresponding to
the central PSY sequence failed to bind, suggesting that a basic
and long b strand conformation is important for interaction. Cam-
KII peptide (ATRNFS) is notably distinct from TARPg2 in that R494 Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc.substitutes for P. While this peptide occupies the same position
in the co-crystal (Figure S3C), the affinity of binding is 760 mM
(Figures S3C and S3D), consistent with TARPg2(P227R) (Fig-
ure 4E). These observations predict a consensus sequence P
[STVILMKR][FYH] in the basic context of a b strand secondary
structure. The consensus is similar but distinct from binding sites
for phosphotyrosine binding domain (PTB) (Zhou et al., 1996) or
FERM domain (Brahme and Calderwood, 2012) proteins.
A search of the Swiss-Prot protein database for Arc N-lobe
consensus identified several synaptic proteins. We focused
on proteins that were recently implicated in genetic studies of
schizophrenia (Fromer et al., 2014; Purcell et al., 2014) since
several reportedly co-precipitate with tandem affinity tagged
Arc or NMDA receptor (including CaMKIIa and b) (Ferna´ndez
et al., 2009; Husi et al., 2000) or play a role in actin dynamics
(Fromer et al., 2014) (Figure 5A and Figure S5D). To assess
whether these are natural binding partners of Arc N-lobe, we
expressed representative proteins IQSEC2 (aa 1,329–1,385)
and WAVE1 (aa 301–343) as GST-fusion proteins and deter-
mined that they bind Arc N-lobe (Figure S4). FP assays
confirmed Arc binding to WAVE1, GKAP, IQSEC2, and GluN2A
and estimated their affinity of binding from 11 mM to 160 mM
(Figure 5B). GST pull-down assays using Arc N-lobe versus
ArcP217F N-lobe with native proteins from brain detergent ly-
sates confirmed specific binding (Figures 5C and 5D). Natural
association was confirmed in co-immunoprecipitation assays
from brain comparing lysates from WT versus Arc/ forebrain
(Figure S4).
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Figure 4. Arc Selectively Interacts with
TARPs
(A) The 3.5 A˚ Fo-Fc electron density, contoured at
2.5 s, of the Arc N-lobe/TARPg2 peptide complex.
TARPg2 peptide is shown as sticks in purple.
(B) The hydrogen bond contacts between TARPg2
peptide and Arc N-lobe.
(C) Pull-down of TARPg2 fragment (203–247) or
TARP g-3 cytoplasmic fragment (202–249) against
Arc (207–370) using GST-fusion construct.
(D) Pull-down of TARPg2 cytoplasmic tail (203–
323) or its phosphomimic mutant S9D against Arc
(207–370) using GST-fusion construct. Selective
pull-downs of Arc (207–370) is confirmed by
western blot (bottom). TARPg2 phosphomutant
S9D does not bind Arc (207–370).
(E) Competitive inhibition binding curves of mutant
TARPg2 peptide (225- RIPSYR -230) to the Arc
GAG domain detected by FP. pS228 and pY229
are phosphorylated peptides. Tri is tripeptide PSY.
P227R is a variant peptide.Arc N-Lobe Binding Is Inhibited by Chemical
Pharmaceuticals
The robust FP assay afforded an opportunity to screen for
chemical agents that might inhibit Arc-N-lobe binding. Typical
protein-protein interactions that are mediated by relatively
large, flat surfaces are difficult to inhibit; however, the peptide
binding groove and hydrophobic pocket required for Arc N-
lobe binding suggested that chemical agents might inhibit
binding. We screened a library of FDA approved compounds
(2,700) (Chong et al., 2007) and initial positives (20) were re-
screened for inhibition of GST-Arc (207–370) binding to TARPg2
(221–247) (Figures S5A and S5B). Thioridazine inhibited binding
with an IC50 of 194 mM; 80% of binding inhibited over 1 log
[Thioridazine] (Figure 5E). The structurally related phenothiazine
Trifluoperazine also inhibited binding but with lower affinity (Fig-
ure S5C), while Chlorpromazine, which has no hexatomic ring to
mimic the aromatic group of side chain in the Arc binding motif,
did not (data not shown). This SAR together with the low IC50,
which for Thioridazine is 104 lower than for D2 dopamine re-Neuron 86, 490–5ceptors (Cohen et al., 1979), indicates
that inhibition of Arc N-lobe binding is
not related to antipsychotic action. These
observations support the feasibility of
pharmacological interruption of Arc bind-
ing but also highlight the challenge of
specificity.
DISCUSSION
The present study provides the first
atomic structure for Arc and reveals
that Arc N- and C-lobes evolved from
the capsid domain of Ty3/Gypsy retro-
transposon. Ty3/Gypsy sequence homo-
logs are recognized by computational
methods in nearly 100 mammalian pro-
teins, and many of these derive from
the Ty3/Gypsy Gag domain (Campillos et al., 2006). Arc is the
only synaptic protein of this class and its structure provides
the first structural information beyond HIV for this group of
genes. In addition to revealing evolutionary adaptations that un-
derlie synaptic functions of Arc, comparison of Arc N-lobe with
HIV NTD reveals evolutionary adaptations that probably
contribute to flexibility between HIV NTD and CTD (Figure S2),
which is important for its unique capsid structure (Pornillos
et al., 2009, 2011). Arc mRNA and protein expression exhibit
several unusual and dynamic regulatory mechanisms that may
be related to Arc’s retrotransposon origin (Volff, 2009). Like
viral genes, Arc mRNA possesses an internal ribosome entry
sequence (IRES) (Pinkstaff et al., 2001), and Arc is rapidly trans-
lated in dendrites in response to signals that inhibit general
mRNA translation (Park et al., 2008). Trafficking of Arc mRNAs
to distal dendrites (Steward et al., 1998) shares cell biological
challenges of retroviral RNA trafficking from the nucleus to the
cell cortex where Gag protein must assemble at the plasma
membrane (Cochrane et al., 2006; Shida, 2012). Host defenses00, April 22, 2015 ª2015 Elsevier Inc. 495
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Figure 5. Arc N-Lobe Binding Partners and
Chemical Inhibition
(A) Arc N-lobe binding sequences from GKAP,
WAVE1, NR2A, and IQSEC2 aligned with TARPg2.
(B) Binding affinity of various binding partners to Arc
(207–370) measured by FP competition assay. These
peptides are GKAP (aa 436–441), WAVE1 (aa 315–
320), NR2A (aa 1,169–1,174), and IQSEC2 (aa 1,329–
1,385).
(C) GST-Arc N(WT) or GST-Arc N(P217F) were used
to pull down native TARPg2, WAVE1, GKAP,
GluN2A, and GluN2B from mouse brains, and the
eluted proteins were blotted with corresponding
antibodies. Arc P217F mutant shows reduced bind-
ing to TARPg2, WAVE1, GKAP, GluN2A, or GluN2B.
(D) Quantification of relative intensity from GST-Arc
N(WT) pull-down versus GST-Arc N(P217F) pull-
down. n = 34; **p < 0.01; ***p < 0.001.
(E) FP competition binding assay demonstrating
Thioridazine inhibition of Arc (207–278) binding to
TARPg2 peptide.against viruses include incorporation of introns in the 30 UTR to
engage non-sense-mediated decay (NMD) (Isken and Maquat,
2007) and microRNAs (Umbach and Cullen, 2009). Arc mRNA
is regulated by both mechanisms (Giorgi et al., 2007; Huang
et al., 2012). Emergence of Arc as a cellular IEG provides a
compelling example of retrotransposon-host co-evolution.
Arc N-lobe binding function emerges via amino acid substitu-
tions that interrupt an intramolecular aromatic stack at the center
of the four helix bundle and consequently create a unique hydro-
phobic pocket that together with a b sheet binding groove medi-
ates intermolecular binding. Arc binding to TARPg2 defines a
protein assembly that presumably includes AMPA receptors
and can mediate Arc-dependent downregulation of AMPA re-
ceptors during homeostatic scaling. Structural features of Arc-
TARPg2 binding and peptide binding experiments predict that
the interaction is regulated by phosphorylation of TARPg2, which
is consistent with physiological effects of TARPg2 phosphoryla-
tion to increase synaptic strength (Opazo et al., 2010; Sumioka
et al., 2010; Tomita et al., 2005). AMPA receptor sensitivity to496 Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc.Arc may also be controlled at the level of
TARP gene expression since TARPg3
evolves to escape Arc binding in higher ver-
tebrates. Arc-N lobe binding to CaMKII is
relatively low affinity but consistent with
the high concentration of CaMKII at synap-
ses, and with a model in which Arc binding
to CaMKII targets Arc to inactive synapses
(Okuno et al., 2012). Identification of an Arc
N-lobe consensus binding motif expands
the protein interaction network for Arc.
The functional role for each of these inter-
actions remains to be defined, but a model
of binding and downregulation similar to
action with TARPg2-AMPA receptor is
consistent with activity-dependent down-
regulation of synaptic NMDA receptors
(Watt et al., 2004), GKAP (Shin et al.,
2012), and Arc-dependent changes in spine structure (Greer
et al., 2010; Peebles et al., 2010).
The present study provides structural information about the
C-terminal half of Arc that includes a region previously sug-
gested to possess homology with spectrin repeats (Lyford
et al., 1995). We were not able to crystalize full-length Arc, and
consequently the structural basis of several critical functions of
Arc remain unknown. For example, Arc interactions with endo-
philin and dynamin are required for its synaptic function; how-
ever, these interactions are not defined in the present study as
they require a region of the N-terminal half of Arc (Chowdhury
et al., 2006). Based on sequence analysis, we hypothesize the
Arc N-terminal half includes a-helical regions and mediates as-
sociations with phospholipids and endocytic proteins. In this
model, Arc N-lobe defines the target specificity in Arc-depen-
dent trafficking of specific proteins from the plasma membrane
and cytosol in endocytic vesicle pathways.
The Arc N-lobe binding consensus is similar to the NPXY
sequence that is present in the cytosolic domains of several
transmembrane proteins important in synaptic function including
integrins, growth factor receptors, LDL receptor family, and am-
yloid precursor protein (APP) (Chen et al., 1990; Pandey, 2010).
The NPXY motif is bound by proteins that encode phosphotyro-
sine binding domains (PTB) and FERM domains, which function
in cargo recognition to regulate endocytosis, trafficking, and
function of the transmembrane proteins (Traub and Bonifacino,
2013). In some (but not all) cases, PTB binding is regulated by
tyrosine phosphorylation or receptor ubiquitination (Goh and
Sorkin, 2013), and instances of dynamic competition between
multiple binding partners are described (Brahme and Calder-
wood, 2012). Crystal structures of NPXY bound to PTB/FERM
domains reveals distinct binding mode and conformation of
the ligand compared to Arc N-lobe (Dvir et al., 2012; Ghai
et al., 2013). Nevertheless, Arc might represent a competitive
mechanism for binding and alternative endocytic trafficking for
these membrane proteins.
Arc N-lobe binding partners include protein products of genes
linked to schizophrenia (Fromer et al., 2014; Purcell et al., 2014).
In genetic studies of schizophrenia, certain genes were grouped
as part of an Arc complex based on their co-precipitation with
tagged Arc, while other genes were grouped as part of a sepa-
rate NMDA receptor complex or of an actin dynamics complex.
Since mutations are rare in schizophrenia patients, grouping is
important to reach a statistical association with disease. Arc N-
lobe binding provides an alternative criterion for clustering genes
linked to schizophrenia that merges components of each of
these three groupings. Nearly half of the synaptic genes with
large deletions associated with schizophrenia (see extended
data Table 3 in Purcell et al., 2014) possess an Arc N-lobe
consensus binding sequence (Figure S5D). To date, mutations
reported in schizophrenia do not implicate Arc itself, which
together with the present data, suggests the shared property
of rare mutations linked to schizophrenia may be that they result
in accentuation of processesmediated by Arc that downregulate
neuronal excitability at individual synapses (Be´ı¨que et al., 2011;
Jakkamsetti et al., 2013; Park et al., 2008; Waung et al., 2008)
or in cell-wide adaptations to altered cellular or network activity
(Shepherd et al., 2006). The observation that Arc-N lobe binding
can be inhibited by chemical pharmaceuticals suggests that the
action of Arc to downregulate synaptic proteins may be a
feasible target for therapeutics although it remains to be seen if
agents with sufficient specificity can be discovered. Our studies
anticipate the development of genetic and pharmacological
tools to test the hypothesized role of Arc in physiology and
disease.EXPERIMENTAL PROCEDURES
Expression Constructs and Antibodies
All the expression constructs were made by PCR and the PCR products were
cloned into expression vectors pGEX-6P-1 (GE Healthcare) or pSinRep5 (Invi-
trogen). Point mutants were made using Quick Change Site-Directed Muta-
genesis Kit (Stratagene). The sequence of the primers used to generate
each mutant will be supplied upon request. All constructs were verified by
DNA sequencing.
GluA1 antibody was kindly provided by Dr. Richard Huganir (Johns Hopkins
University). Monoclonal Arc antibody was generated in Monoclonal Antibody
Core at Johns Hopkins University using Arc C-terminal (155–396) as antigen.The other antibodies were purchased from commercial sources: Stargazin
(Millipore), b-actin (Sigma).
Protein Expression and Purification
The cDNAs of Rn Arc (Genbank: NP_062234) N-lobe and C-lobe domains (res-
idues 207277 and 278370, respectively) were subcloned into vector pGEX-
6P-1 (GE Healthcare) between the EcoRI and XhoI restriction sites for bacterial
expression as a GST-fusion protein. The transfected E. coliBL21(DE3) cell cul-
ture was grown at 37C until OD600 nm reached 0.6. The temperature was
reduced to 25C, and cells were induced with 0.2 mM isopropyl-b-D-thioga-
lactopyranoside (IPTG) and grown for 16 hr. The cells were harvested and
lysed by sonicating in PBS (pH 7.3) supplemented with 1% Triton X-100.
The recombinant protein in the supernatant of the cell lysate was mixed with
Glutathione Sepharose resin (GE Healthcare), and the mixture was washed
extensively in PBS with 1% Triton X-100. After cleaving with Precision prote-
ase overnight to remove the GST tag, the protein was purified by using Q Se-
pharose Fast Flow and Superdex 75 size-exclusion chromatography, and was
exchanged into a buffer of 20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 1 mM
DTT (dithiothreitol) and was concentrated to 15 mg/ml immediately before
crystallization. Selenomethionyl-substituted protein was expressed and puri-
fied as WT. All point mutants of RnArc (207–370) were expressed and purified
similarly to the WT.
The cDNAs of mouse TARPg2 (Genbank: NP_031609) cytoplasmic region
(residues 203323, 203-247, and 221247, respectively), TARP g-3 (Gen-
bank: NP_062303) cytoplasmic region (residues 202–249), IQSEC2 fragment
(aa 1,329–1,385, Genbank: NP_001108136) and WAVE1 (aa 301–343, Gen-
bank: NP_114083) and CAMK2A peptide (Genbank: NP_803126, residues
278-329) were cloned from a mouse brain cDNA library. The cDNA clone of
Xenopus tropicalis Arc (XP_004918984, residues 168–266) was obtained
from Dr. Sabrina S. Burmeister of University of North Carolina Department of
Neurobiology (Mangiamele et al., 2006). These constructs were subcloned
into vector pGEX-6P-1 (GEHealthcare) between the EcoRI and XhoI restriction
sites for expression in E. coli. The construct of the GST-fusion S9D was ob-
tained from Dr. Susumu Tomita of the Yale University School of Medicine (Su-
mioka et al., 2010). All recombinant proteins contained an N-terminal GST-tag
and were purified with GSH-affinity chromatography. (221–247) and CaMKIIa
peptide (278–329) were further purified by SP Sepharose Fast Flow after
removing the GST tag.
Crystallography Studies
Recombinant protein Arc C-lobe (278–370) was crystallized using the hanging
drop vapor diffusion method. The protein sample (15 mg/ml) was mixed with
an equal volume (2+2 ml) of the precipitant solution containing 1 M sodium cit-
rate and 0.1 M imidazole (pH 8.0). The best-diffracting crystals grew as plates
to their maximum size of 0.2 3 0.8 3 0.8 mm in about 10 days at 20C. Co-
crystallization of Arc N-lobe (207–277) and (221–247) with molar ratio 1:2
was performed under a crystallization condition 0.2 M Potassium sulfate,
20% PEG 3350 and 0.1 M MES (pH 6.5). The best-diffracting crystals grew
as rods to their maximum size of 0.2 3 0.2 3 1.2 mm in about two weeks at
4C. Co-crystallization of Arc N-lobe (207–277) and CAMK2A peptide (278–
329) with molar ratio 1:2 was grown under a crystallization condition 2M
ammonium sulfate and 0.1 M Tris (pH 8.0). The best-diffracting crystals grew
as blocks to their maximum size of 0.2 3 0.2 3 0.4 mm in about one and
half a months at 20C.
For the crystal of Arc C-lobe and co-crystal of Arc N-lobe with CaMKIIa pep-
tide, X-ray diffraction data were collected at beamline 23-ID at the Argonne
National Laboratory from a flash-cooled crystal after soaking the crystal in a
cryo-protectant solution containing 15% (v/v) glycerol. For the complexed
crystal of Arc N-lobe with fragment, X-ray diffraction data were collected on
Rigaku FR-E X-ray generator with the detector of a Saturn 944+ CCD. Data
were processed, scaled, and merged using the HKL2000 program package
(Otwinowski and Minor, 1997).
Phases of the Arc C-lobe crystal structure and the co-crystal of Arc N-lobe
with CaMKIIa peptide were solved by the Se-based single-wavelength anom-
alous dispersionmethod (Hendrickson and Ogata, 1997)39393938 using the pro-
gramPHENIX (Adams et al., 2010) and the data at the Se-absorption edge. The
electron density map calculated at 2.0 A˚ resolution was readily interpretable.Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc. 497
Model building was performed using the program COOT (Emsley and Cowtan,
2004) guided by 2FoFc and FoFc difference Fourier electron density maps.
Atomic coordinates were refined with iterative cycles of manual building using
COOT (Emsley and Cowtan, 2004), REFMAC (Vagin et al., 2004), and PHENIX
(Adams et al., 2010). Phases of the crystal structure of the Arc N-lobe- complex
were determined by the molecular replacement method using the program
MOLREP (Vagin and Teplyakov, 2010) and the Arc N-lobe complex with
CaMKIIa peptide as the search template, and refined similarly as above. Final
X-ray data collection and refinement statistics are presented in Table S1. All
structure figures were prepared with program Pymol (Schro¨dinger).
Fluorescence Polarization Assay
5-Carboxyfluorescein (FAM) labeled peptide (RIPSYR) (GenScript) was dis-
solved in 10 mM Tris-Cl (pH 8.0), 0.5% NP-40 and 100 mM NaCl. Purified
wild-type ormutant Arc (202–370) protein samples were diluted with the above
buffer andmixed with 5 nM FAM labeled peptides. Themixtures were assayed
in black 384 well plates with the Tecan Safire2 Microplate Reader (Tecan
Group). Data were analyzed and plotted using program GraphPad Prism
version 5.0 (GraphPad Software). Fluorescence polarization competition
assay followed protocol (Moerke, 2009; Roehrl et al., 2004) using synthesis
peptides of various TARPg2 mutant, GKAP (aa 436–441, NP_808307),
WAVE1 (aa 315–320, NP_114083), NR2A (aa 1,169–1,174, NP_032196), and
purified fragment of IQSEC2 (aa 1,329–1,385, NP_001108136).
GST Pull-Down Assay
E.coli expressed GST or GST fusion protein that is immobilized on glutathione-
Sepharose beads was used to incubate with E.coli expressed protein or brain
lysate at 4C for 4 hr to overnight. After incubation, glutathione-Sepharose
beads were washed with 0.51.0% Triton X-100 buffer (in PBS) three times.
Elutes from beads were used for either SDS-PAGE gel electrophoresis and
Coomassie blue staining or western blotting with specific antibody.
Co-Immunoprecipitation
C57BL/6 mouse brain was sonicated in 20 volumes of lysis buffer (PBS [pH
7.4], 1% Triton X-100, 5 mM EDTA, 5 mM EGTA) containing Complete
EDTA-Free protease inhibitor (Roche) and PhosSTOP phosphatase inhibitor
(Roche). The brain lysate was centrifuged at 161,000 3 g for 15 min and the
supernatant was mixed with 1 mg Arc monoclonal antibody for 4 hr at 4C.
Then, 60 ml of 50% Protein G Sepharose slurry (Amersham-Pharmacia
Biotech) was added for an additional 2 hr. The protein beads were washed
three times with lysis buffer containing 1% Triton X-100. The protein samples
were eluted with SDS loading buffer and analyzed by gel electrophoresis and
western blotting.
Recombinant Sindbis Virus Production and Infection
ArcWT or Arc P217F was subcloned into pIRES2-EGFP vector and then trans-
ferred into pSinRep5 (Invitrogen). All constructs were verified by sequencing.
To generate pseudovirions, we first generated recombinant RNA and helper
RNA using mMESSAGE mMACHINE SP6 Transcription kit (Ambion). Sindbis
pseudovirions were produced following the manufacture protocol for Sindbis
Expression System (Invitrogen). At 11–14DIV, cultured neurons were infected
with virus. Experiments were performed 12–16 hr after infection.
Primary Cortical Neuronal Culture
High-density cortical cultures from embryonic day 18 (E18) C57/Bl6 mouse
pups were prepared as reported previously (Wu et al., 2011) with minor alter-
ations. For surface biotinylation experiments, 1 3 106 neurons were added to
each well of a 6-well plate (Corning) coated with poly-L-lysine. For recording
experiments, 2 3 106 neurons were added to each 60 mm dish (Corning) with
coverslips coatedwith poly-L-lysine. Growthmediumconsisted of NeuroBasal
(Invitrogen) supplemented with 1% fetal bovine serum (Hyclone), 2% B27, 1%
Glutamax (Invitrogen), 100 U/ml penicillin, and 100 U/ml streptomycin (Invitro-
gen). Neurons were fed twice per week with glia conditioned growth medium.
Surface Biotinylation Assay
For surface biotinylation, infected cortical neurons were cooled on ice, washed
twice with ice-cold PBS containing 1 mM CaCl2 and 0.5 mM MgCl2, and then498 Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc.incubated with PBS containing 1 mM CaCl2, 0.5 mM MgCl2, and 1 mg/ml
Sulfo-NHS-SS-Biotin (Pierce) for 30 min at 4C. Unreacted biotin was
quenched by washing cells three times with ice-cold 100 mM glycine (pH
7.4). Cultures were harvested in RIPA buffer. Cell lysate was sonicated and
centrifuged at 132,000 rpm for 20min at 4C. 15% of the resulting supernatant
was saved as the ‘‘total’’ protein samples. The remaining 85%of the lysatewas
rotated overnight at 4C with NeutrAvidin beads (Pierce). Precipitates were
washed with RIPA buffer and analyzed by western blotting with indicated
antibodies.
Electrophysiology and mEPSC Analysis
Whole-cell patch-clamp recordings were performed from cortical cultures. To
isolate AMPAR-mediated mEPSCs, we continuously perfused neurons with
artificial cerebral-spinal fluid (aCSF) including 124 mM NaCl, 2.5 mM KCl,
2.5 mM CaCl2, 1.3 mM MgCl2, 26.2 mM NaHCO3, 10 mM glucose, 0.01 mM
gabazine, and 0.001 mM tetrodotoxin. Intracellular saline consisted of the
following: 135 mM Cs-MeSO4, 10 mM CsCl, 10 mM HEPES, 5 mM EGTA,
2 mM MgCl2, 4 mM Na-ATP, and 0.1 mM Na-GTP adjusted to the osmolarity
of 305–310 and 7.3–7.4 pH. Transfected neurons were selected based on fluo-
rescent (eGFP) signal. Once the whole-cell recording configuration was
achieved, neurons were voltage clamped, and passive properties were moni-
tored throughout. In the event of a change in series resistance (Rs) or input
resistance (Ri) >15% during the course of a recording, the data were excluded
from the set. mEPSCs were acquired through a MultiClamp 700B amplifier
(Axon Instruments), filtered at 2 kHz, and digitized at 5 kHz. Sweeps of 20 s
with zero latency were acquired until a sufficient number of events were re-
corded (a minimum of 5 and no longer than 30 min). Data were recorded
continuously only after a period of 5 min, during which the cell was allowed
to stabilize. mEPSCswere detectedmanually with miniAnalysis software (Syn-
aptosoft) by setting the amplitude threshold to O RMS 3 3 (usually 4 pA). Once
aminimum of 100 events had been collected from a neuron, the amplitude and
frequency were measured. In all electrophysiological experiments, a similar
amount of data was acquired from both ArcWT and Arc P217F overexpressing
neurons on the same day. Data from each group were then averaged and sta-
tistical significance was determined by Student’s t test.
ACCESSION NUMBERS
Atomic coordinates and X-ray structure factors have been deposited in the
Protein Data Bank with accession numbers PDB: 4X3X (Arc C-lobe), PDB:
4X3H (Arc N-lobe with TARPg2 peptide) and PDB: 4X3I (Arc N-lobe with CaM-
KIIa peptide).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.neuron.2015.03.030.
AUTHOR CONTRIBUTIONS
W.Z. and P.F.W. designed the experiments. J.W. designed and carried out all
in vivo experiments. J.W. constructed Arc mutants. M.D.W. collected X-ray
data, and D.J.L. supervised analysis. S.Y. recorded and analyzed electrophys-
iological data. W.Z. performed all other experiments. W.Z. and J.W. made fig-
ures. W.Z. and J.W. contributed to the writing of the manuscript. D.J.L. and
P.F.W. wrote the final manuscript.
ACKNOWLEDGMENTS
Diffraction data for this study were measured at beamline X29 of the National
Synchrotron Light Source with the generous assistance of Annie Heroux.
Financial support comes principally from the Offices of Biological and Environ-
mental Research and of Basic Energy Sciences of the U.S. Department of En-
ergy, and from the National Center for Research Resources (P41RR012408)
and the National Institute of General Medical Sciences (P41GM103473) of
the National Institutes of Health. We thank Alan Long for fluorescence
polarization assay andChris Ross, DanielWeinberger, and JeremyNathans for
helpful comments. Thanks to Susumu Tomita (Yale University School of Med-
icine) and Sabrina S. Burmeister (University of North Carolina) for Stargazin
S9D construct and Xenopus tropicalis Arc cDNA clone, respectively. This
work was supported by NIMH grant RO1MH053608 (P.F.W.), NARSAD Young
Investigator Grant (J.W.) and Biogen Idec.
Received: January 16, 2015
Revised: March 7, 2015
Accepted: March 7, 2015
Published: April 9, 2015
REFERENCES
Adams, P.D., Afonine, P.V., Bunko´czi, G., Chen, V.B., Davis, I.W., Echols, N.,
Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., et al. (2010).
PHENIX: a comprehensive Python-based system for macromolecular struc-
ture solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221.
Be´ı¨que, J.C., Na, Y., Kuhl, D., Worley, P.F., and Huganir, R.L. (2011). Arc-
dependent synapse-specific homeostatic plasticity. Proc. Natl. Acad. Sci.
USA 108, 816–821.
Brahme, N.N., and Calderwood, D.A. (2012). Cell adhesion: a FERM grasp of
the tail sorts out integrins. Curr. Biol. 22, R692–R694.
Campillos, M., Doerks, T., Shah, P.K., and Bork, P. (2006). Computational
characterization of multiple Gag-like human proteins. Trends Genet. 22,
585–589.
Chen, W.J., Goldstein, J.L., and Brown, M.S. (1990). NPXY, a sequence often
found in cytoplasmic tails, is required for coated pit-mediated internalization of
the low density lipoprotein receptor. J. Biol. Chem. 265, 3116–3123.
Chong, C.R., Xu, J., Lu, J., Bhat, S., Sullivan, D.J., Jr., and Liu, J.O. (2007).
Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem.
Biol. 2, 263–270.
Chowdhury, S., Shepherd, J.D., Okuno, H., Lyford, G., Petralia, R.S., Plath, N.,
Kuhl, D., Huganir, R.L., and Worley, P.F. (2006). Arc/Arg3.1 interacts with the
endocytic machinery to regulate AMPA receptor trafficking. Neuron 52,
445–459.
Cochrane, A.W., McNally, M.T., and Mouland, A.J. (2006). The retrovirus RNA
trafficking granule: from birth to maturity. Retrovirology 3, 18.
Cohen, B.M., Herschel, M., and Aoba, A. (1979). Neuroleptic, antimuscarinic,
and antiadrenergic activity of chlorpromazine, thioridazine, and their metabo-
lites. Psychiatry Res. 1, 199–208.
Dvir, H., Shah, M., Girardi, E., Guo, L., Farquhar, M.G., and Zajonc, D.M.
(2012). Atomic structure of the autosomal recessive hypercholesterolemia
phosphotyrosine-binding domain in complex with the LDL-receptor tail.
Proc. Natl. Acad. Sci. USA 109, 6916–6921.
Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular
graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132.
Ferna´ndez, E., Collins, M.O., Uren, R.T., Kopanitsa, M.V., Komiyama, N.H.,
Croning, M.D., Zografos, L., Armstrong, J.D., Choudhary, J.S., and Grant,
S.G. (2009). Targeted tandem affinity purification of PSD-95 recovers core
postsynaptic complexes and schizophrenia susceptibility proteins. Mol.
Syst. Biol. 5, 269.
Fromer, M., Pocklington, A.J., Kavanagh, D.H., Williams, H.J., Dwyer, S.,
Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D.M., et al. (2014).
De novo mutations in schizophrenia implicate synaptic networks. Nature
506, 179–184.
Ghai, R., Bugarcic, A., Liu, H., Norwood, S.J., Skeldal, S., Coulson, E.J., Li,
S.S., Teasdale, R.D., and Collins, B.M. (2013). Structural basis for endosomal
trafficking of diverse transmembrane cargos by PX-FERMproteins. Proc. Natl.
Acad. Sci. USA 110, E643–E652.
Giorgi, C., Yeo, G.W., Stone, M.E., Katz, D.B., Burge, C., Turrigiano, G., and
Moore, M.J. (2007). The EJC factor eIF4AIII modulates synaptic strength and
neuronal protein expression. Cell 130, 179–191.Goelet, P., Castellucci, V.F., Schacher, S., and Kandel, E.R. (1986). The long
and the short of long-term memory—a molecular framework. Nature 322,
419–422.
Goh, L.K., and Sorkin, A. (2013). Endocytosis of receptor tyrosine kinases.
Cold Spring Harb. Perspect. Biol. 5, a017459.
Greer, P.L., Hanayama, R., Bloodgood, B.L., Mardinly, A.R., Lipton, D.M.,
Flavell, S.W., Kim, T.K., Griffith, E.C., Waldon, Z., Maehr, R., et al. (2010).
The Angelman Syndrome protein Ube3A regulates synapse development by
ubiquitinating arc. Cell 140, 704–716.
Guzowski, J.F., McNaughton, B.L., Barnes, C.A., and Worley, P.F. (1999).
Environment-specific expression of the immediate-early gene Arc in hippo-
campal neuronal ensembles. Nat. Neurosci. 2, 1120–1124.
Hendrickson, W.A., and Ogata, C.M. (1997). Phase determination from multi-
wavelength anomalous diffraction measurements. Methods Enzymol. 276,
494–523.
Huang, Y.W., Ruiz, C.R., Eyler, E.C., Lin, K., and Meffert, M.K. (2012). Dual
regulation of miRNA biogenesis generates target specificity in neurotrophin-
induced protein synthesis. Cell 148, 933–946.
Husi, H., Ward, M.A., Choudhary, J.S., Blackstock, W.P., and Grant, S.G.
(2000). Proteomic analysis of NMDA receptor-adhesion protein signaling com-
plexes. Nat. Neurosci. 3, 661–669.
Isken, O., and Maquat, L.E. (2007). Quality control of eukaryotic mRNA: safe-
guarding cells from abnormal mRNA function. Genes Dev. 21, 1833–1856.
Jackson, A.C., and Nicoll, R.A. (2011). Stargazing from a new vantage—TARP
modulation of AMPA receptor pharmacology. J. Physiol. 589, 5909–5910.
Jakkamsetti, V., Tsai, N.P., Gross, C., Molinaro, G., Collins, K.A., Nicoletti, F.,
Wang, K.H., Osten, P., Bassell, G.J., Gibson, J.R., and Huber, K.M. (2013).
Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabo-
tropic glutamate receptor-dependent long-term synaptic depression.
Neuron 80, 72–79.
Link,W., Konietzko, U., Kauselmann, G., Krug, M., Schwanke, B., Frey, U., and
Kuhl, D. (1995). Somatodendritic expression of an immediate early gene is
regulated by synaptic activity. Proc. Natl. Acad. Sci. USA 92, 5734–5738.
Llorens, C., Fares, M.A., and Moya, A. (2008). Relationships of gag-pol diver-
sity between Ty3/Gypsy and Retroviridae LTR retroelements and the three
kings hypothesis. BMC Evol. Biol. 8, 276.
Lyford, G.L., Yamagata, K., Kaufmann, W.E., Barnes, C.A., Sanders, L.K.,
Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Lanahan, A.A., and Worley, P.F.
(1995). Arc, a growth factor and activity-regulated gene, encodes a novel cyto-
skeleton-associated protein that is enriched in neuronal dendrites. Neuron 14,
433–445.
Mangiamele, L.A., Thomson, C.J., Lebonville, C.L., and Burmeister, S.S.
(2006). Characterization of the plasticity-related gene, Arc, in the frog brain.
Dev. Neurobiol. 70, 813–825.
Mattaliano,M.D., Montana, E.S., Parisky, K.M., Littleton, J.T., and Griffith, L.C.
(2007). The Drosophila ARC homolog regulates behavioral responses to star-
vation. Mol. Cell. Neurosci. 36, 211–221.
Moerke, N.J. (2009). Fluorescence Polarization (FP) Assays for Monitoring
Peptide-Protein or Nucleic Acid-Protein Binding. Curr. Protoc. Chem. Biol.
1, 1–15.
Møller, T.C., Wirth, V.F., Roberts, N.I., Bender, J., Bach, A., Jacky, B.P.,
Strømgaard, K., Deussing, J.M., Schwartz, T.W., and Martinez, K.L. (2013).
PDZ domain-mediated interactions of G protein-coupled receptors with post-
synaptic density protein 95: quantitative characterization of interactions. PLoS
ONE 8, e63352.
Niere, F., Wilkerson, J.R., and Huber, K.M. (2012). Evidence for a fragile X
mental retardation protein-mediated translational switch in metabotropic
glutamate receptor-triggered Arc translation and long-term depression.
J. Neurosci. 32, 5924–5936.
Okuno, H., Akashi, K., Ishii, Y., Yagishita-Kyo, N., Suzuki, K., Nonaka, M.,
Kawashima, T., Fujii, H., Takemoto-Kimura, S., Abe, M., et al. (2012). Inverse
synaptic tagging of inactive synapses via dynamic interaction of Arc/Arg3.1
with CaMKIIb. Cell 149, 886–898.Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc. 499
Opazo, P., Labrecque, S., Tigaret, C.M., Frouin, A., Wiseman, P.W., De
Koninck, P., and Choquet, D. (2010). CaMKII triggers the diffusional trapping
of surface AMPARs through phosphorylation of stargazin. Neuron 67,
239–252.
Otwinowski, Z., and Minor, W. (1997). Processing of x-ray diffreaction data
collected in oscillation mode. Methods Enzymol. 276, 307–326.
Pandey, K.N. (2010). Small peptide recognition sequence for intracellular sort-
ing. Curr. Opin. Biotechnol. 21, 611–620.
Park, S., Park, J.M., Kim, S., Kim, J.A., Shepherd, J.D., Smith-Hicks, C.L.,
Chowdhury, S., Kaufmann, W., Kuhl, D., Ryazanov, A.G., et al. (2008).
Elongation factor 2 and fragile Xmental retardation protein control the dynamic
translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59, 70–83.
Peebles, C.L., Yoo, J., Thwin, M.T., Palop, J.J., Noebels, J.L., and Finkbeiner,
S. (2010). Arc regulates spine morphology and maintains network stability
in vivo. Proc. Natl. Acad. Sci. USA 107, 18173–18178.
Pinkstaff, J.K., Chappell, S.A., Mauro, V.P., Edelman, G.M., and Krushel, L.A.
(2001). Internal initiation of translation of five dendritically localized neuronal
mRNAs. Proc. Natl. Acad. Sci. USA 98, 2770–2775.
Plath, N., Ohana, O., Dammermann, B., Errington,M.L., Schmitz, D., Gross, C.,
Mao, X., Engelsberg, A., Mahlke, C., Welzl, H., et al. (2006). Arc/Arg3.1 is
essential for the consolidation of synaptic plasticity and memories. Neuron
52, 437–444.
Pornillos, O., Ganser-Pornillos, B.K., Kelly, B.N., Hua, Y., Whitby, F.G., Stout,
C.D., Sundquist, W.I., Hill, C.P., and Yeager, M. (2009). X-ray structures of the
hexameric building block of the HIV capsid. Cell 137, 1282–1292.
Pornillos, O., Ganser-Pornillos, B.K., and Yeager, M. (2011). Atomic-level
modelling of the HIV capsid. Nature 469, 424–427.
Purcell, S.M., Moran, J.L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P.,
O’Dushlaine, C., Chambert, K., Bergen, S.E., Ka¨hler, A., et al. (2014). A poly-
genic burden of rare disruptive mutations in schizophrenia. Nature 506,
185–190.
Roehrl, M.H., Wang, J.Y., and Wagner, G. (2004). A general framework for
development and data analysis of competitive high-throughput screens for
small-molecule inhibitors of protein-protein interactions by fluorescence po-
larization. Biochemistry 43, 16056–16066.
Shepherd, J.D., Rumbaugh, G., Wu, J., Chowdhury, S., Plath, N., Kuhl, D.,
Huganir, R.L., and Worley, P.F. (2006). Arc/Arg3.1 mediates homeostatic syn-
aptic scaling of AMPA receptors. Neuron 52, 475–484.
Shida, H. (2012). Role of Nucleocytoplasmic RNA Transport during the Life
Cycle of Retroviruses. Front Microbiol 3, 179.500 Neuron 86, 490–500, April 22, 2015 ª2015 Elsevier Inc.Shin, S.M., Zhang, N., Hansen, J., Gerges, N.Z., Pak, D.T., Sheng,M., and Lee,
S.H. (2012). GKAP orchestrates activity-dependent postsynaptic protein re-
modeling and homeostatic scaling. Nat. Neurosci. 15, 1655–1666.
Steward, O., Wallace, C.S., Lyford, G.L., and Worley, P.F. (1998). Synaptic
activation causes the mRNA for the IEG Arc to localize selectively near acti-
vated postsynaptic sites on dendrites. Neuron 21, 741–751.
Sumioka, A., Yan, D., and Tomita, S. (2010). TARP phosphorylation regulates
synaptic AMPA receptors through lipid bilayers. Neuron 66, 755–767.
Tomita, S., Chen, L., Kawasaki, Y., Petralia, R.S., Wenthold, R.J., Nicoll, R.A.,
and Bredt, D.S. (2003). Functional studies and distribution define a family of
transmembrane AMPA receptor regulatory proteins. J. Cell Biol. 161, 805–816.
Tomita, S., Stein, V., Stocker, T.J., Nicoll, R.A., and Bredt, D.S. (2005).
Bidirectional synaptic plasticity regulated by phosphorylation of stargazin-
like TARPs. Neuron 45, 269–277.
Traub, L.M., and Bonifacino, J.S. (2013). Cargo recognition in clathrin-medi-
ated endocytosis. Cold Spring Harb. Perspect. Biol. 5, a016790.
Umbach, J.L., and Cullen, B.R. (2009). The role of RNAi and microRNAs in an-
imal virus replication and antiviral immunity. Genes Dev. 23, 1151–1164.
Vagin, A., and Teplyakov, A. (2010). Molecular replacement with MOLREP.
Acta Crystallogr. D Biol. Crystallogr. 66, 22–25.
Vagin, A.A., Steiner, R.A., Lebedev, A.A., Potterton, L., McNicholas, S., Long,
F., and Murshudov, G.N. (2004). REFMAC5 dictionary: organization of prior
chemical knowledge and guidelines for its use. Acta Crystallogr. D Biol.
Crystallogr. 60, 2184–2195.
Volff, J.N. (2009). Cellular genes derived from Gypsy/Ty3 retrotransposons in
mammalian genomes. Ann. N Y Acad. Sci. 1178, 233–243.
Watt, A.J., Sjo¨stro¨m, P.J., Ha¨usser, M., Nelson, S.B., and Turrigiano, G.G.
(2004). A proportional but slower NMDA potentiation follows AMPA potentia-
tion in LTP. Nat. Neurosci. 7, 518–524.
Waung, M.W., Pfeiffer, B.E., Nosyreva, E.D., Ronesi, J.A., and Huber, K.M.
(2008). Rapid translation of Arc/Arg3.1 selectively mediates mGluR-depen-
dent LTD through persistent increases in AMPAR endocytosis rate. Neuron
59, 84–97.
Wu, J., Petralia, R.S., Kurushima, H., Patel, H., Jung, M.Y., Volk, L.,
Chowdhury, S., Shepherd, J.D., Dehoff, M., Li, Y., et al. (2011). Arc/Arg3.1 reg-
ulates an endosomal pathway essential for activity-dependent b-amyloid gen-
eration. Cell 147, 615–628.
Zhou, M.M., Huang, B., Olejniczak, E.T., Meadows, R.P., Shuker, S.B.,
Miyazaki, M., Tru¨b, T., Shoelson, S.E., and Fesik, S.W. (1996). Structural basis
for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat.
Struct. Biol. 3, 388–393.
